Skip to Content

WPI 844 (Glipizide Extended Release 5 mg)

Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 844

Glipizide extended release 5 mg WPI 844
Glipizide extended release 5 mg WPI 844 Front
Glipizide extended release 5 mg WPI 844 Back
Glipizide extended release 5 mg WPI 844

Glipizide Extended Release

Imprint
WPI 844
Strength
5 mg
Color
Orange
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
acetyltributyl citrate, ammonia, butyl alcohol, ferrosoferric oxide, hydroxyethyl cellulose (2000 cps at 1%), isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 400, propylene glycol, shellac, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0844 Watson Pharmaceuticals, Inc.
68084-0111 Amerisource Health Services
10370-0190 Anchen Pharmaceuticals, Inc.
54569-5547 A-S Medication Solutions, LLC (repackager)
54868-5210 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "WPI 844"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.